Fig. 3. The tumor growth rates of the different studied groups. A. Tumor growth rates showing a higher rate for the parent SEC tumors. Two-way ANOVA analysis was done. Data are expressed as mean ± SD.B. Tumor growth rates for SEC and SEC/CDDP tumors before and after kicking off the treatment. The growth rate of SEC/CDDP tumors was higher than the parental SEC tumors before the treatments were given. SEC: solid Ehrlich carcinoma, CDDP: cisplatin, SEC/CDDP: CDDP-resistant SEC.